Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$27,000.00
Exercise to Enhance Cancer Immunotherapy for Acute Myeloid Leukemia
EF 2024-25
Résumé
Acute myeloid leukemia (AML) is one of the most common forms of blood cancer in adults, with low 5-year survival rates of around 20%. Leveraging the immune system’s ability to target cancer cells, our research group has developed an innovative treatment strategy for AML called double-negative T (DNT) cell therapy. In this approach, a unique immune cell type known as DNT cells are extracted from healthy donors, ‘trained’ with anti-cancer activity, and infused into patients. A key factor for successful immune cell-based therapy is the health and fitness of immune cells used for patient treatment. Research has shown that exercise can enhance immune cell function conducive to greater anti-cancer activity and rejuvenate the immune system by replacing exhausted cells with fitter cells. Building on this knowledge, there is an opportunity to maximize the therapeutic potential of DNT cell therapy by exercising the donors prior to immune cell donation; however, the impact of exercise on DNT cell therapy has not been previously studied. This project aims to test the hypothesis that the immune benefits of exercise can be harnessed to enhance DNT cell therapy for AML. Based on maximal exercise testing, donors will be determined ‘trained’ (n=8) or ‘untrained’ (n=8) to investigate the role of physical fitness on the biology and therapeutic potential of DNT cells. Subsequently, the untrained donors will undergo a 6-week high-intensity interval training program to examine exercise-induced changes in the composition and anti-cancer activity of DNT cells before, during, and after the exercise intervention. With ongoing and planned clinical trials using DNT cell therapy for AML, the findings from this study will be swiftly translated into clinical practice to benefit the patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530307
Name
Lee Heejae
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exercise to Enhance Cancer Immunotherapy for Acute Myeloid Leukemia
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Myeloid Leukemia; Adoptive Cellular Therapy; Cancer; Cancer Immunology; Double-Negative T Cells; Exercise; Exercise Immunology; Exercise Physiology; Immunotherapy; Transdisciplinary Research
Abstract
Acute myeloid leukemia (AML) is one of the most common forms of blood cancer in adults, with low 5-year survival rates of around 20%. Leveraging the immune system’s ability to target cancer cells, our research group has developed an innovative treatment strategy for AML called double-negative T (DNT) cell therapy. In this approach, a unique immune cell type known as DNT cells are extracted from healthy donors, ‘trained’ with anti-cancer activity, and infused into patients. A key factor for successful immune cell-based therapy is the health and fitness of immune cells used for patient treatment. Research has shown that exercise can enhance immune cell function conducive to greater anti-cancer activity and rejuvenate the immune system by replacing exhausted cells with fitter cells. Building on this knowledge, there is an opportunity to maximize the therapeutic potential of DNT cell therapy by exercising the donors prior to immune cell donation; however, the impact of exercise on DNT cell therapy has not been previously studied. This project aims to test the hypothesis that the immune benefits of exercise can be harnessed to enhance DNT cell therapy for AML. Based on maximal exercise testing, donors will be determined ‘trained’ (n=8) or ‘untrained’ (n=8) to investigate the role of physical fitness on the biology and therapeutic potential of DNT cells. Subsequently, the untrained donors will undergo a 6-week high-intensity interval training program to examine exercise-induced changes in the composition and anti-cancer activity of DNT cells before, during, and after the exercise intervention. With ongoing and planned clinical trials using DNT cell therapy for AML, the findings from this study will be swiftly translated into clinical practice to benefit the patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Heejae
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~